Back 

Search in our transfection database

Search for publications in the Transfection Database with Polyplus-transfection reagents or for transfection conditions.

Over 4000 publications, 1000 cell lines and primary cells available.

Order by :  
Found 17 results :
Targeted Organin vitro
in vivo
Delivered MoleculeReagentResults & Citations
Brainin vivoDNA, siRNAjetSI 10 mM
Hassani, Z., Lemkine, G. F., Erbacher, P., Palmier, K., Alfama, G., Giovannangeli, C., Behr, J. P., Demeneix, B. A. (2005)

J Gene Med 7, 198-207
Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels
More details
Brainin vivosiRNAjetSI 10 mM
Li, F., Wu, N., Su, R., Chen, Y., Lu, X., Liu, Y., Li, J. (2012)

Addict Biol 17, 392-408
Imidazoline receptor antisera-selected/Nischarin regulates the effect of agmatine on the development of morphine dependence
More details
Brainin vivosiRNAjetSI 10 mM
Smith, K. L., Herron, B., Dowell-Mesfin, N., Wu, H., Kim, S. J., Shain, W., Hynd, M. R. (2012)

J Neurosci Methods 203, 398-406
Knockdown of cortical transthyretin expression around implanted neural prosthetic devices using intraventricular siRNA injection in the brain
More details
Brainin vivosiRNAjetSI 10 mM
Tai, D. J., Hsu, W. L., Liu, Y. C., Ma, Y. L., Lee, E. H. (2011)

Embo J 30, 205-20
Novel role and mechanism of protein inhibitor of activated STAT1 in spatial learning
More details
Brainin vivosiRNAjetSI 10 mM
Zhang, Z. H., Yu, Y., Wei, S. G., Felder, R. B. (2012)

Am J Physiol Heart Circ Physiol 302, H742-51
Aldosterone-induced brain MAPK signaling and sympathetic excitation are angiotensin II type-1 receptor dependent
More details
Brainin vivosiRNAjetSI 10 mM
Yamazaki, R., Baba, H., Yamaguchi, Y. (2018)

Neurochem Res 43, 195-204
Unconventional Myosin ID is Involved in Remyelination After Cuprizone-Induced Demyelination
More details
Brainin vivosiRNAjetSI 10 mM
Youm, I., West, M. B., Li, W., Du, X., Ewert, D. L., Kopke, R. D. (2017)

Int J Pharm 528, 611-623
siRNA-loaded biodegradable nanocarriers for therapeutic MAPK1 silencing against cisplatin-induced ototoxicity
More details

Give your feedback!